| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/29/2004 | WO2004009549A2 Piperidines useful for the treatment of central nervous system disorders |
| 01/29/2004 | WO2004009547A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 01/29/2004 | WO2004009546A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 01/29/2004 | WO2004009544A1 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 01/29/2004 | WO2004009533A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 01/29/2004 | WO2004009017A2 Modulators of the glucocorticoid receptor and method |
| 01/29/2004 | WO2004008859A1 Fused-benzene derivatives of thiouracil, herbicidal and desiccant compositions contaning them |
| 01/29/2004 | WO2003078396A8 Preparation of n1-(2’-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines |
| 01/29/2004 | WO2003053923A3 Pyrrolidine derivatives as prostaglandin modulators |
| 01/29/2004 | WO2003053366A3 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 01/29/2004 | US20040019217 Dihydoxyhexanoic acid derivatives, their intermediates, and methods of making |
| 01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2004 | US20040019211 Crystal structured fungicides selected from itraconazole, posaconazole or saperconazole used for prevention or prophylaxis of fungi, yeasts and dermatophyte infections |
| 01/29/2004 | US20040019208 5-Aryltetrazole Compounds, compositions thereof, and uses therefor |
| 01/29/2004 | US20040019190 Thrombopoietin mimetics |
| 01/29/2004 | US20040019113 Phosphate transport inhibitors |
| 01/29/2004 | US20040019103 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
| 01/29/2004 | US20040019099 Treating inflammatory diseases, allergic conditions and central nervous system disorders |
| 01/29/2004 | US20040019098 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 01/29/2004 | US20040019094 N-imine guanidine compounds; treatment of obesity, anorexia, inflammation and mental disorders |
| 01/29/2004 | US20040019092 Non-peptide somatostatin receptor ligands |
| 01/29/2004 | US20040019079 Beta3-Adrenoreceptor agonists, agonist compositions and methods of using |
| 01/29/2004 | US20040019077 Heterocyclic imines such as N1-(8-sulfonamide-5-isoquinoline)-N2-(3,3-diphenyl-2-propenyl) -ethylenediamine, used for prophylaxis and diagnosis of cancers, diabetes, cardiovascular and nervous system disorders, autoimmune diseases or obesity |
| 01/29/2004 | US20040019044 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals |
| 01/29/2004 | US20040019041 Method for the production of imidazo-(1,2-C)(2,3)-benzodiazepines and intermediates in the production thereof |
| 01/29/2004 | US20040019039 Substituted piperazines and diazepanes |
| 01/29/2004 | US20040019038 Compounds useful as anti-inflammatory agents |
| 01/29/2004 | US20040019037 E.g.,((5-(2,4-Diaminopyrimidin-6-yl)pentanoyl)-(N-methyl)amino )-3-(6-meth-oxypyridin-3-yl)-propanoic acid, inhibition of bone resorption, restenosis, angiogenesis inhibitors, antiarthritic, -tumor, -carcinogenic agents; antidiabetic |
| 01/29/2004 | US20040018986 Viricide against hepatitis virus |
| 01/29/2004 | US20040018941 Applying to plants; synergistic mixture |
| 01/29/2004 | US20040018192 Integrin expression inhibitors |
| 01/29/2004 | DE10229777A1 Indolin-Phenylsulfonamid-Derivate Indoline derivatives phenylsulfonamide |
| 01/29/2004 | CA2493876A1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 01/29/2004 | CA2493721A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 01/29/2004 | CA2493458A1 Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations |
| 01/29/2004 | CA2493457A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 01/29/2004 | CA2493339A1 2-cyano-4-fluoropyrrolidine derivative or salt thereof |
| 01/29/2004 | CA2492911A1 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 01/29/2004 | CA2492907A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/29/2004 | CA2492847A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 01/28/2004 | EP1384737A2 Cycloaliphatic epoxy compounds containing styrenic, cinnamyl, or maleimide functionality |
| 01/28/2004 | EP1384720A1 Process for drying paroxetine hydrochloride |
| 01/28/2004 | EP1384713A1 4-amino-azepan-3-one derivatives as protease inhibitors |
| 01/28/2004 | EP1384711A1 Optical resolution of a piperidine derivative |
| 01/28/2004 | EP1383763A2 Method for producing 2- -5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane |
| 01/28/2004 | EP1383761A1 Phenyl- and pyridyl-piperidines with tnf activity |
| 01/28/2004 | EP1383760A1 Biarylcarboxamide compounds as apolipoprotein b inhibitors |
| 01/28/2004 | EP1383759A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
| 01/28/2004 | EP1383757A1 Antagonists of mcp-1 function and methods of use thereof |
| 01/28/2004 | EP1383746A2 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 01/28/2004 | EP1383744A1 Novel piperidine derivatives as modulators of chemokine receptor |
| 01/28/2004 | EP1383731A1 Biaryl compounds as serine protease inhibitors |
| 01/28/2004 | EP0794947B1 N-substituted hydrazinophenylsulphonyl ureas used as herbicides and plant-growth regulators |
| 01/28/2004 | CN1471536A Chemokine receptor antagonsis and method of use thereof |
| 01/28/2004 | CN1471527A 喹唑啉衍生物 Quinazoline derivatives |
| 01/28/2004 | CN1471526A Dioxolane analogs for improved inter-cellular delivery |
| 01/28/2004 | CN1471524A Novel farnesyl protein transferase inhibitors as antitumor |
| 01/28/2004 | CN1471523A Imidazole derivatives as Raf kinase inhibitors |
| 01/28/2004 | CN1471521A Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same |
| 01/28/2004 | CN1471520A Aminoalkyl benzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/28/2004 | CN1471519A Amino alkyenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/28/2004 | CN1471515A Compounds effective as beta-2-adrenoreceptor agonists as well as PDE-4-inhibitors |
| 01/28/2004 | CN1471511A Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 01/28/2004 | CN1136217C 4-aryloxindoles as inhibitor of JNK protein kinases |
| 01/28/2004 | CN1136215C Isoquinoline derivatives or salts thereof |
| 01/28/2004 | CN1136198C Novel benzyl pyrimidines |
| 01/28/2004 | CN1136197C Novel pyridajinone derivatives |
| 01/28/2004 | CN1136192C Aryl and hetaryl-sulfonamide derivatives, their preparation and use as endo thelin antagonists |
| 01/28/2004 | CN1136189C Substituted heterocyclic compounds, preparing method thereof and pharmaceutical composition containig them |
| 01/28/2004 | CN1136183C Process for producing optically active mevalonolactone compound |
| 01/28/2004 | CN1136042C Flow device for the reduction of compounds from biological compositions and methods of use |
| 01/27/2004 | US6683213 Chemical intermediates for pyridinedicarboxamide herbicides |
| 01/27/2004 | US6683142 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators |
| 01/27/2004 | US6683097 Imidazole derivatives |
| 01/27/2004 | US6683096 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 01/27/2004 | US6683095 CDK inhibitors having 3-hydroxychromen-4-one structure |
| 01/27/2004 | US6683093 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
| 01/27/2004 | US6683091 Heterocyclic sulfanamides; alzheimer's disease; preventing deposition of amyloid protein |
| 01/27/2004 | US6683079 Reverse transcriptase inhibitors |
| 01/27/2004 | US6683078 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/27/2004 | US6683029 Halopyrimidines |
| 01/27/2004 | CA2256247C New naphtalene compounds, their preparation and pharmaceutical compositions containing them |
| 01/22/2004 | WO2004007510A1 Novel chemical substance having activity for morphogenesis and growth promotion |
| 01/22/2004 | WO2004007483A1 Novel macrocycles for the treatment of cancer diseases |
| 01/22/2004 | WO2004007481A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders |
| 01/22/2004 | WO2004007476A1 Gesellschaft für biotechnologische forschung mbh (gbf) |
| 01/22/2004 | WO2004007463A1 Cck-1 receptor modulators |
| 01/22/2004 | WO2004007458A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
| 01/22/2004 | WO2004007457A2 Substituted benzylamine derivatives and methods of use |
| 01/22/2004 | WO2004007454A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 01/22/2004 | WO2004007453A1 Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
| 01/22/2004 | WO2004007444A2 N-hydroxyamide derivatives possessing antibacterial activity |
| 01/22/2004 | WO2004006922A1 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia |
| 01/22/2004 | WO2004006846A2 Receptor-type kinase modulators and methods of use |
| 01/22/2004 | WO2003055447A3 Heterocyclic acridone inhibitors of impdh enzyme |
| 01/22/2004 | WO2003049690A3 Hiv integrase inhibitors |
| 01/22/2004 | WO2002092573A3 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
| 01/22/2004 | WO2002072093A3 Use of dual h3/m2 antagonists with a bipiperidinic structure in the treatment of cognition deficit disorders |
| 01/22/2004 | US20040014995 Chromene compounds |
| 01/22/2004 | US20040014983 Chlorinating benzisoxazole methane sulfonic acid with thionyl chloride to form an intermediate of benzisoxazole methane sulfonamide |